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Glycine N-methyltransferase (GNMT) is a key regulatory
enzyme in methyl groupmetabolism. It is abundant in the liver,
where it uses excess S-adenosylmethionine (AdoMet) tometh-
ylate glycine to N-methylglycine (sarcosine) and produces
S-adenosylhomocysteine (AdoHcy), thereby controlling the
methylating potential of the cell. GNMT also links utilization
of preformed methyl groups, in the form of methionine, to
their de novo synthesis, because it is inhibited by a specific
form of folate, 5-methyltetrahydrofolate. Although the struc-
ture of the enzyme has been elucidated by x-ray crystallogra-
phy of the apoenzyme and in the presence of the substrate, the
location of the folate inhibitor in the tetrameric structure has
not been identified.We report here for the first time the crys-
tal structure of rat GNMT complexed with 5-methyltetrahy-
drofolate. In the GNMT-folate complex, two folate binding
sites were located in the intersubunit areas of the tetramer.
Each folate binding site is formed primarily by two 1–7 N-ter-
minal regions of one pair of subunits and two 205–218
regions of the other pair of subunits. Both the pteridine and
p-aminobenzoyl rings are located in the hydrophobic cavities
formed by Tyr5, Leu207, and Met215 residues of all subunits.
Binding experiments in solution also confirm that one
GNMT tetramer binds two folate molecules. For the enzy-
matic reaction to take place, the N-terminal fragments of
GNMTmust have a significant degree of conformational free-
dom to provide access to the active sites. The presence of the
folate in this position provides amechanism for its inhibition.
The methylation of nucleic acids, proteins, and small mole-
cules in the cells is one of the most important ways of modulat-
ingmetabolism and development. Eachmethylation reaction is
carried out by a specific enzyme, but all such reactions are
dependent on the concentrations of the substrate, AdoMet,2
and of the product of the reaction, AdoHcy. That ratio
AdoMet/AdoHcy is considered an index of the methylation
capacity of the cell (1, 2).
One of the key regulatory elements in maintaining the
AdoMet/AdoHcy ratio is the enzyme glycine N-methyl-
transferase (3, 4). This enzyme, which catalyzes the methyl-
ation of glycine, is considered to be a tool for the removal of
an excess of AdoMet when its concentration in the cell is
increased (increased dietary methionine). Inactivation of
GNMT by missense mutations in human individuals
resulted in highly elevated concentrations of AdoMet and
methionine in the patient’s plasma (5, 6). Model mice with
the Gnmt gene completely knocked out have an extremely
high concentration of AdoMet and a high ratio of AdoMet/
AdoHcy in the liver (7).
An important finding wasmade when amajor folate-binding
protein in rat liver cytosol was identified as GNMT (8–10).
That discovery immediately raised questions as to how this
enzyme operates in the cell in the presence of folate, how
GNMT is related to folate metabolism, and what is the biolog-
ical role of the enzyme. A unique property of GNMT methyl-
transferase is that it was found that binding of the 5-methyltet-
rahydrofolate pentaglutamate (5-CH3-H4PteGlu5) inhibits
methyltransferase activity ofGNMT (11). This confers a special
role for the enzyme by which it links the activity of the enzyme
in the transfer of preformedmethyl groups arising frommethio-
nine via AdoMet to the de novo synthesis ofmethyl groups byway
of the folate one-carbon pool. A regulatory scheme was proposed
in which GNMT not only maintains the AdoMet/AdoHcy ratio
but also controlsmethyl group synthesis (12). The structure of the
GNMT-folate complex is obviously of great importance, but until
now, no such crystal structure was available.
The crystal structures of the rat, mouse, and human
GNMT apoproteins (13, 14) are known as well as the rat
GNMT complexed either with AdoMet or complexed with
AdoHcy (15–17). The overall structures of GNMTs from
various species are very similar. All enzymes are tetramers of
flat shape with numerous contacts between subunits and
lower density in the center of the tetramer (see Fig. 1). Each
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subunit possesses an active center where AdoMet and gly-
cine are bound deep inside of the globular part of the sub-
units. The enzymatic reaction starts with the AdoMet bind-
ing, which leads to significant conformational changes,
especially in the N-terminal parts of each monomer, as
shown by crystallization of rat GNMT with AdoMet,
AdoMet with acetate anion, and by the kinetic data (16–17).
The active centers of GNMT could bind some other com-
pounds as shown in the crystal structures of the human and
mouse enzymes, where Tris or citrate molecules from the
mother liquors were found (14). By protein-ligand docking
modeling, it was shown that benzopyrene could potentially
bind to the active center of GNMT (18). Does that mean that
folates could also bind to the active center, as proposed ear-
lier (15)?
The crystal structure determination of the folate-GNMT
complex nowprovides insight to themechanism and specificity
of inhibition by folate and its link to one-carbon metabolism in
the cell. In this work, we report the crystal structure of rat
GNMT complexed with 5-methyltetrahydrofolate.
EXPERIMENTAL PROCEDURES
GNMT Preparation—All experiments in this work were
done with rat GNMT, as this enzyme was discovered as the
folate-binding protein in rat liver, and folate binding in vitrohas
been described for this enzyme (11). In addition, the crystal
structure of the rat enzyme has been relatively well studied (13,
15–17). Rat GNMT was expressed in E. coli and purified as
reported earlier (19). Briefly, rat GNMT cDNA was cloned in
pET-17b expression vector and expressed in the BL21(GE3)
E. coli strain. After preparation of the crude extract, GNMT
was purified by ammonium sulfate precipitation, DE-52 anion
exchange chromatography, and Sephacryl S-200 size exclusion
chromatography. Protein of 96–98% purity was used for crys-
tallization and other experiments.
Folate Binding—All experiments of folate binding and
crystallization were done with (6S)-5-methyltetrahydrofo-
late monoglutamate ((6S)-5-CH3-H4PteGlu, hereafter
referred to as folate) (Fig. 1) from Merck EPROVA AG,
Schaffhausen, Switzerland. This derivative of folic acid was
used because it is a basic natural form of folate, it is available
in large quantities suitable for crystallization studies, and it
has been shown to inhibit and bind to the rat liver enzyme
(11, 20). Binding to GNMT was measured by a filtration
method. The rat enzyme was incubated with folate in 20 mM
Tris, 25 mM NaCl, and 5 mM Tris(2-carboxyethyl)phosphine
hydrochloride (TCEP), pH 7.5, for 1 h. The material was
placed into a Microcon YM-10 concentrator (Amicon Bio-
separation), and a small volume of the solvent with unbound
folate was quickly separated by centrifugation. Concentra-
tion of folate in the filtrate [Ffree] was measured by absorb-
ance at 290 nm (maximum for folate at neutral pH) by using
a molar extinction coefficient of 3.17  104 (21). Subtracting
the free concentration of folate from the total concentration
gave us the concentration of bound folate [Fbound]. The
molar ratio of [Fbound]/[GNMTtetr] (V), with [GNMTtetr] as a
molar concentration of GNMT tetramer, was plotted against
[Ffree], and the resulting plot was fitted with the following
equation: V  nKA[Ffree]/(1  KA[Ffree]) (by KaleidaGraph
(Synergy Software) non-linear fitting algorithm according to
Refs. 22 and 23). The n and KA parameters are the total
number of ligand molecules bound to GNMT tetramer and
an association constant, respectively.
Crystallization—The GNMT-folate complex was crystal-
lized by the sitting drop method at room temperature. The
protein (4–6 mg/ml concentration in 20 mM Tris-HCl, pH 7.5,
25mMNaCl, 5mMTCEP)was incubatedwith 1–3mM folate for
at least 1 h prior to the crystallization. The protein-folate com-
plex was mixed with the reservoir solution (20% polyethylene
glycol 3350, 0.2 M calcium-acetate). The crystals of the GNMT-
folate complex appeared in a few hours and grew to the maxi-
mum dimensions in 4–6 days. They belong to the monoclinic
P21 space group with a  57.869, b  85.223, and c  131.861
Å and   91.40°. Crystals of the GNMT apoprotein were
grown from the same conditions, with folate being omitted
from the crystallization, and they are isomorphous with the
GNMT-folate crystals.
X-rayDataCollection—Prior to the data collection, a suitable
crystal was dipped for several seconds in a modified mother
FIGURE 1. Structures of GNMT and (6S)-5-CH3H4PteGlu. The GNMT apopro-
tein structure is that obtained in this work (PDB accession code 2IDJ). Protein
subunits A, B, C, and D are shown in green, magenta, orange, and blue, respec-
tively. The side chains of residues in active centers participating in the inter-
actions with AdoMet (PDB accession code 1NBH; Ref. 17) are shown in black.
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liquor solution with the addition of 20% ethylene glycol as a
cryoprotectant and frozen in liquid nitrogen. Diffraction data
were collected at 100 K at Southeast Regional Collaborative
Access Team (SER-CAT) beamline 22-BM, Advanced Photon
Source, Argonne National Laboratory, using a MAR 225
CCD detector. The images were processed and scaled using
HKL2000 (24). Data collection and data processing statistics
are summarized in Table 1.
Structure Solution and Refinement—The structure of the
apoGNMTwas solved by themolecular replacement procedure
as implemented in the CNS package (25). A dimer of the rat
GNMT (Protein Data Bank (PDB) accession code 1BHJ) was
used as the search model. Two dimers, which form a tetramer,
were located in the asymmetric unit. The tetramer in the
GNMT-folate structure was positioned using the rigid body
refinement of the apoGNMT tetramer. The positioned tet-
rameric models of both the apo- and folate-bound structures
were then refined using the maximum likelihood refinement in
CNS (25). Two-fold non-crystallographic symmetry restraints
and bulk solvent corrections were applied. The programO (26)
was used to build the models throughout the refinement.
Refinement statistics for both structures are listed in Table 1.
Details of refinement of each of the structures follow.
GNMT Apoprotein—The final model consists of residues
2–196, 200–223, and 235–292 of subunit A, residues 1–227
and 235–292 of subunit B, residues 2–223 and 235–292 of sub-
unit C, residues 1–227 and 233–292 of subunit D, two Ca2
ions, and 115 water molecules. Residues C246 (subunit B) and
R53 (subunit D) were modeled in two alternate conformations.
Themolecules display good stereochemistrywith 87.9%of non-
glycine residues in themost favored regions of a Ramachandran
plot and none in disallowed regions.
GNMT-Folate Complex—The difference Fourier map re-
vealed the presence of two folate molecules in the tetramer of
GNMT. They were modeled according to the shape of electron
density. Their occupancy factor was set to 1. The final model
consists of residues 2–196, 200–223, and 235–292 of subunitA,
residues 1–227 and 235–292 of subunit B, residues 1–223 and
235–292 of subunit C, residues 1–227 and 233–292 of subunit
D, two folates, and 14 water molecules. Similar to the apopro-
tein, 85.0% of non-glycine residues are in the most favored
regions of a Ramachandran plot and none are in disallowed
regions.
Other Methods—Protein concentration was routinely deter-
mined by the BCA method (BCA protein assay kit, Pierce)
according to the manufacturer’s protocol, with bovine serum
albumin as a standard. In binding experiments, concentration
was determined spectrophotometrically by using an absorb-
ance value of 1.46 for a 0.1% solution at 278 nm in binding
conditions. The latter was experimentally determined based on
the value of 1.50 predicted from the amino acid composition for
solution in 6 M guanidine hydrochloride. The BCA method
gives a concentration 7.7% higher compared with the spectro-
photometrically determined value; therefore, the coefficient of
0.929 was used to obtain the correct concentration.
Protein purity was determined by standard SDS electro-
phoresis with scanning of the Coomassie-stained gel on Bio-
RadGel/ChemiDoc systemandQuantityOne software.Micro-
biological assay for folate was done by the Lactobacillus casei
microbiological assay according to a published procedure (27).
Absorbance spectrawere recorded on a double beamShimadzu
UV-2401 spectrophotometer.
RESULTS
Folate Binding to GNMT—The binding data are presented in
Fig. 2 as the dependence of the molar ratio of folate bound to
GNMT (tetramer) on the concentration of free folate [Ffree].
Fitting the data by the equation described under “Folate Bind-
ing” gave the value of the ratio of [Fbound]/[GNMTtetr]  2
(1.944). That means that one molecule of GNMT tetramer
binds twomolecules of folate. The value of the association con-
stant KA was calculated to be 3.42  105  M1 (or 2.9 M for
KD). The latter means that crystallization experiments should
be performed at a millimolar concentration of folate to follow a
general suggestion to use a ligand concentration of 1000-fold
higher than KD.
Crystallization—The major requirements for crystallization
conditions were to maintain a pH of 7 for effective folate
binding to GNMT in the ionization state similar to physiologic
conditions and the presence of reducing agent to prevent oxi-
dative degradation of 5-CH3-H4PteGlu. Several crystallization
conditions were found to be favorable for GNMT-folate com-
plex crystal growth. The best crystals were obtained in the pres-
ence of calcium-acetate in 20% polyethylene glycol 3350 (Fig.
3A) and a folate concentration of 1–3 mM with 5 mM TCEP. In
those conditions, crystals of GNMT-folate complex appeared
TABLE 1






Resolution (Å) 50-2.35 50-2.55
Space group P21 P21
Cell dimensions
a (Å) 57.869 57.427
b (Å) 85.223 84.751
c (Å) 131.861 132.245
 (°) 91.40 91.61
Unique reflections 53 782 38 846
Rsyma,b (%) 6.6 (45.6) 5.2 (45.0)
Completeness (%) 99.9 (99.8) 94.5 (89.0)
Redundancy 3.5 (2.9) 4.8 (4.5)
I/(I) 25.0 (2.9) 29.9 (1.9)
Refinement
Reflections used in refinement 47,869 36,594
 Cutoff used in refinement None None
R/Rfreec (%) 22.2/27.2 23.9/29.7





Root mean square deviations
Bond lengths (Å) 0.006 0.007
Bond angles (°) 1.2 1.3
Average B factor (Å2)
Protein 50.0 60.1
Folate 93.2
a Values in parentheses are for the highest-resolution shell.
bRsym  Ii  Ii/Ii, where Ii is the intensity of the ith observation and Ii is the
mean intensity of the reflection.
c R  Fo  Fc/Fo, where Fo and Fc are the observed and calculated structure
factors amplitudes. Rfree is calculated using 4.7 and 4.3% of reflections omitted
from the refinement for the GNMT apoprotein and GNMT-folate complex
respectively.
GNMT-Folate Structure
FEBRUARY 9, 2007 • VOLUME 282 • NUMBER 6 JOURNAL OF BIOLOGICAL CHEMISTRY 4071
in hours. The shape of the crystals for the complex was as
shown in Fig. 3A.
One of the critical points of this work was obtaining crys-
tals of GNMT apoprotein grown under the same conditions
as for the GNMT-folate complex. Such crystals give the best
comparison of crystal structures of the folate-free protein
and the GNMT-folate complex, avoiding any question of
potential effects of different components of the precipitants
and buffers. The latter was of special importance, because
GNMT is known for its ability to trap some components of
the crystallization media (14). In most cases, the apoprotein
crystals were grown in the form of tiny needles not suitable
for data collection (Fig. 3B). However, in two drops in calci-
um-acetate, two plate-shaped crystals of GNMT apoprotein
grew to a relatively large size.
The presence of folate in the GNMT-folate complex crystals
was confirmed by microbiological assay (27). Additional evi-
dence for the presence of folate in the GNMT-folate crystals
was an observation that crystals, after five months of storage in
mother liquor, became yellow- and red-colored, and the inten-
sity of the color increased over time, yet the mother liquor
remained clear (Fig. 3C).None of the crystals ofGNMTwithout
folate became colored, even after storage for a year in the
mother liquor. The red color could be explained by a shift of the
absorbance spectra to400 nm due to folate oxidation to a still
unidentified “red product” (28, 29). None of the GNMT-folate
complex crystals were used for data collection later than one
week after crystal growth initiation.
Overall Structures—The asymmetric unit in the folate-
free as well as the GNMT-folate complex is represented by a
tetramer in a so-called closed conformation. Important fea-
tures of that structure are the positions of the N-terminal
fragments of the subunits, which were found interacting
with residues of the entrance into the active center of the
adjacent subunits (16, 17).
The overall conformation did not change upon folate
binding. Folate-free and folate-bound structures are very
similar, with root mean square deviations of 0.738 Å over the
1129 equivalent CA atoms. In addition, flexible parts of the
protein molecules (parts of protein model for which no elec-
tron density has been observed) are almost identical and
similar to those found in the structures of human and mouse
GNMTs (14).
Despite a very similar overall structure, there are some dif-
ferences. An important one is a difference in the conformations
of Tyr5 residues, especially Tyr5 (A) and Tyr5 (D). In the
GNMT-folate complex, those tyrosine residues play an impor-
tant role in folate binding.
Localizing the Folate Binding Sites—The principal goal of
this work was to localize the folate binding sites in the rat
GNMT. Difference Fourier electron density map contoured
at 4  for the GNMT-folate complex revealed the presence of
two areas of additional electron density located in the inter-
subunit area (Fig. 4A). The shape of the density was consist-
ent with a folate molecule. On the contrary, no additional
electron density has been observed in the same area for the
apoprotein (Fig. 4B). Because the binding experiment
showed that the GNMT tetramer binds two folate molecules,
it was concluded that the additional electron density origi-
nated from folate.
Folate Conformation—Folates and their derivatives exist in
complexeswith proteins in different conformationswith differ-
ent relative orientation of the pteridine ring, p-aminobenzoyl
(PABA) group, and glutamate residue(s), which depend on the
specific folate-protein interactions (30, 31). Two general con-
formations of folates were found. Themost abundant one is the
bent conformation, as found in dihydrofolate reductase and
other enzymes (32). In crystal structures of enzymes with
5-CH3-H4PteGlu and with 5-CH3-H4PteGlu5, some contain
folate in the bent conformation, whereas others contain folate
in the extended form (32–35). The best assignment of the folate
in the electron density in the GNMT-folate complex was
achieved when the folate was built in almost extended confor-
mation as shown in Fig. 5.
Folate-Protein Interactions—The folate conformation is sup-
ported by specific folate-GNMT interactions. The interaction
of folate with the GNMT protein moiety followed the general
rule for the folate-protein interaction; the pteridine and p-ami-
nobenzoyl rings were buried into the more hydrophobic inte-
FIGURE 3. Crystals of rat GNMT. A, GNMT-folate complex. B, apoprotein.
C, GNMT-folate crystals after six months of storage in crystallization
solution.
FIGURE 2. Binding of 5-CH3-H4PteGlu by rat GNMT. Rat recombinant GNMT
incubated with folate of different concentrations in 20 mM Tris-HCl, 25 mM
NaCl, 5 mM TCEP, pH 7.5, 1 h on ice. Part of the solution was separated from
protein by filtration, and the concentration of free folate was measured by
absorbance at 290 nm. The molar ratio of bound folate/GNMT tetramer (V)
calculated and plotted against free folate concentration. Fitted value for n is
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rior of the proteinwith the glutamate tail exposed to the surface
of the protein globule. The characteristic feature of folate-
GNMT binding is that the folate binding sites are located in
very specific parts of the quaternary structure of GNMT in the
intersubunit areas.
As shown in Fig. 5, binding site 1 is located between sub-
units B and D in the cavity formed by two interacting parts of
all four subunits, two -sheets formed by residues Ser205–
Thr218 (B) and Ser205–Thr218 (D) on the one side and two
N-terminal fragments including residues Asp2–Thr7 (A) and
Val1–Thr7 (C) on the other side. Binding site 2 is related by
2-fold non-crystallographic symmetry to site 1 and is located
between subunits A and C. This site is formed by similar
elements of the polypeptide chains as for binding site 1, two
-sheets formed by residues of Ser205–Thr218 (A) and
Ser205–Thr218 (C) and two N-terminal fragments Val1–Thr7
(B) and Val1-Thr7 (D).
The specific interactions are shown in Fig. 6 and in Table
2 for binding site 1, having in mind that similar interactions
exist in the site 2. Folate molecules are stabilized inside of a
tetramer by mainly hydrophobic interactions with only one
hydrogen bond observed. Such a feature explains the rela-
tively high B-factors of folates, which are 1.5 times higher
than the average B-factors of protein molecules (Table 1).
Within a distance of 4.0 Å from the folate there are residues
Ser3 (C), Tyr5 (A, C), Thr7 (C), Leu207 (B, D), His214 (D),
Met215 (B, D), and Arg239 (B). The hydrophobic pocket of
binding site 1 is formed primarily by Tyr5, Leu207, His214, and
Met215 residues (Table 2).
The pteridine ring interacts with the protein mainly by
hydrophobic contacts. There are numerous such contacts (a
total of 15 as determined by the Ligand Explorer program (36))
that involve Tyr5 (C) with close contact to C7 of the pteridine,
themethyl groups of Leu207 (B), which are at a distance of 2.9 Å
fromC7pteridine andothers as shown inTable 2. The 5-methyl
group of folate is directed into a hydrophobic cavity of GNMT
with the closest distance to themethyl group of Thr7 (A) (3.4 Å)
and the methylene group of Tyr5 (C) (3.5 Å).
The PABAmoiety of folate is placed in themost hydrophobic
part of the binding site (with 19 hydrophobic contacts) as
shown in Fig. 6 andTable 2. Tyr5 (A)
and Leu207 (D) give themain yield in
hydrophobic interactions with
PABA (17 contacts). There is also a
possibility for polar interaction,
because theNH2 group ofArg239 (B)
is a distance of 3.6 Å from the CAO
group of PABA.
The glutamate part of the folate
participates in the most specific
interactions with protein. The only
hydrogen bond between folate and
protein is established between the
-carboxyl group of glutamate and
the hydroxyl group of Tyr5 (A) with
a distance of 3.2 Å (Fig. 6) (3.0 Å in
site 2). The -carboxyl group is
involved in interaction with the sul-
FIGURE 4. Difference Fourier electron density maps contoured at 4  cal-
culated for the GNMT-folate (A) and GNMT apoprotein (B) structures.
Two areas of additional extended electron density in the map of the GNMT-
folate complex are clearly visible. No additional electron density was found
on the GNMT apoprotein map. In B, only the central part of the map and
model is shown.
FIGURE 5. Stereo view of folate-protein secondary structure interactions and position of folate in elec-
tron density map. The relative positions of the folates and elements of the secondary structure of the protein
in the folate binding site 1 are shown. The fragments from subunits A, B, C, and D are colored as in Fig. 1.
Electron density Fo  Fc simulated annealed, omitting the 2.55 Å resolution map for the omitted folate mole-
cule calculated at 4 , is shown.
GNMT-Folate Structure
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fur atomofMet215 (D)with adistancebetweenoxygens and sulfur
atomsof3.10and3.25Å. Interestingly, therearealso13hydropho-
bic contacts of glutamate with Tyr5, Leu207, and His214.
DISCUSSION
Glycine N-methyltransferase is a major liver regulatory
enzyme that plays a key role in maintaining one of the most
important cell parameters, the AdoMet/AdoHcy ratio, often
referred to as themethylation index. In cases when GNMTwas
inactivated by missense mutations in humans (5, 6) or com-
pletely knocked out by gene targeting in mice (7), the concen-
trations of critically important metabolites, methionine, and
AdoMet in human plasma and in mice liver were extremely
high. The latter leads to damage of the liver and liver disease.
GNMT is also a major liver cytosolic folate-binding protein.
Its high abundance in the liver (4) results in themajor portion (if
not all) of 5-methyltetrahydrofolate
tightly bound to GNMT (8). It
should be noted that GNMT is
abundant in other tissues, e.g. in the
pancreas, prostate, and kidney.
Binding of and inhibition by folate is
a key part of the mechanism of con-
trol of the AdoMet/AdoHcy ratio
during the lifetime of the organism.
The crystal structure of the GNMT-
folate complex we are reporting
here gives insight into the mecha-
nism of that regulation.
How is GNMT inhibited by
folate? The crystal structure of
GNMT complexed with 5-methyl-
tetrahydrofolate revealed that
bound folate does not directly inter-
fere with binding of AdoMet by
competing for the active center.
AdoMet is bound to the active site
on each subunit deep into the mon-
omer globule as shown earlier (Fig. 1) (15–17). The AdoMet
binding mechanism deduced from the crystal structure of rat
GNMT with AdoMet indicated that the N-terminal domain of
each subunit hadmoved out of the position where it was block-
ing the entrance to the active site of the adjacent subunit. The
N-terminal fragments then became exposed to solvent (17).
As a result of those rearrangements of the N-terminal frag-
ments of GNMT, the cavities for folate binding are not formed
and folate cannot bind toGNMTwhen the active sites are occu-
pied with AdoMet. The data presented here show explicitly
that, when folate is already bound to GNMT, the N-terminal
fragments are bound to folate and their move from the protein
globule into the solvent to gain access for AdoMet requires
much higher concentrations of AdoMet compared with
apoprotein.
Inhibition experiments (37) support this mechanism. It was
found that 5-methyltetrahydrofolate pentaglutamate inhibited
rat GNMT efficiently if it was incubated with protein prior to
the addition of AdoMet and other components of the reaction
mixture. Obviously, this situation was a result of the difference
in the binding constants for AdoMet and folate and the energy
required for protein conformational changes that accompany
the exposure of theN-terminal parts of themonomers from the
globule into the solvent. It should be noted that these earlier
experiments indicated that there was only a single molecule of
folate bound per tetramer. They were carried out using fluores-
cence determination of the free and total bound folate, and the
calculation employed Scatchard analysis, a much less rigorous
procedure. In addition, the form of folate used in these earlier
studies was the pentaglutamate. It is possible, but unlikely, that
the different result was because of the length of the polygluta-
mate chain.
Localization of the folate binding sites in the rat GNMT is
important in understanding themechanismof inhibition of this
enzyme by folate, which is responsible for regulating the meth-
ylation status of the cell. The data presented here are likely valid
FIGURE 6. Stereo view of folate interactions with amino acid residues in the binding site 1. The residues,
within 4 Å distance from folate with a major yield into folate-protein interactions are shown. The residues are
colored as in Fig. 1. The dotted line indicates the hydrogen bond. The distances between specific groups and
atoms of folate and protein are presented in Table 2.
TABLE 2
5-CH3-H4PteGlu – GNMT interactions
Total hydrophobic contacts of folate-protein is 45, hydrogen bonds 1. Only






C4 CB-Ser3 (C) 3.68
C6 CE-Met215 (B) 3.69
C7 CD2-Leu207 (B) 2.91
C7 CD1-Tyr5 (C) 3.26
5-CH3 CB-Tyr5 (C) 3.53
5-CH3 CG2-Thr7 (A) 3.41
PABA
C12 CB, CG-Tyr5 (A) 3.44, 3.46
C13 CB, CG-Tyr5 (A) 3.38, 3.88
C17 CD2-Leu207 (D) 3.88
CO NH2-Arg239 (B) 3.59
Glutamate
-COO S-Met215 (D) 3.10, 3.25
-COO ND1-His214 (D) 3.41
-COO HO-Tyr5 (A), H-bond 3.19 (3.0 in site 2)
CA CZ-Tyr5 (A) 3.68
CB CZ-Tyr5 (A) 3.11
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for GNMT from other sources. All residues participating in
folate binding in the rat GNMT are invariant in the protein
sequences of GNMTs from rat, human, rabbit, pig, and mouse
(14, 38).
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